Arvinas, Inc. (ARVN)
NASDAQ·Healthcare·Biotechnology
$8.62
-1.15%
Mkt Cap $561.98M
Analyst Ratings
Buy
9
Hold
2
Sell
0
Price Target (36 analysts)
$14.75
Range $10.00 – $20.00
Implied Upside
+71.2%
Consensus $14.75 vs current $8.62
NASDAQ·Healthcare·Biotechnology
$8.62
-1.15%
Mkt Cap $561.98M
Buy
9
Hold
2
Sell
0
Price Target (36 analysts)
$14.75
Range $10.00 – $20.00
+71.2%
Consensus $14.75 vs current $8.62